Grace Therapeutics Inc. (GRCE)
NASDAQ: GRCE
· Real-Time Price · USD
3.10
-0.01 (-0.32%)
At close: Sep 24, 2025, 3:59 PM
3.15
1.61%
After-hours: Sep 24, 2025, 06:31 PM EDT
-0.32% (1D)
Bid | 3.04 |
Market Cap | 42.87M |
Revenue (ttm) | 8K |
Net Income (ttm) | -10.31M |
EPS (ttm) | -0.76 |
PE Ratio (ttm) | -4.08 |
Forward PE | -3.42 |
Analyst | Buy |
Dividends | n/a |
Ask | 3.18 |
Volume | 63,080 |
Avg. Volume (20D) | 80,179 |
Open | 3.08 |
Previous Close | 3.11 |
Day's Range | 3.08 - 3.13 |
52-Week Range | 1.75 - 4.97 |
Beta | 1.06 |
Ex-Dividend Date | n/a |
About GRCE
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol GRCE
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for GRCE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts7 months ago
+8.33%
Grace Therapeutics shares are trading higher after...
Unlock content with
Pro Subscription